About
Jeff Parker is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company, having served as Managing Partner and Director since February 2018 prior to its IPO. He previously was President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) until its $69 million merger with PLx Pharma Inc., served as a board member of Abeona Therapeutics and as President and board member of MacroChem, and held executive roles at Bioenvision, Inc. Parker began his career as a certified public accountant at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.
Founder at Parkervision
Co-founders at Parkervision
Experience
- Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP)President and Chief Executive Officercurrent2017 β presentNew York City Metropolitan Area
- Digital Prime TechnologiesChairmancurrent2019 β presentNew York City Metropolitan Area
- Ameri Holdings, Inc.Chairman of the Board of Directors2018 β 2019
- PLx Pharma Inc.Director2017
- Dipexium PharmaceuticalsPresident & CEO, Director2010 β 2017
- Access Pharmaceuticals, Inc.Director2007 β 2010New York, New York
- MacroChem CorporationPresident & Director2007 β 2009New York, New York
- Bioenvision, Inc. (Nasdaq: BIVN)Executive Vice President, CFO and General Counsel2002 β 2007New York, New York
- Paul, Hastings, Janofsky & Walker LLPCorporate Attorney1994 β 2002
- Ernst & Young LLPSenior Auditor1988 β 1991
Skills & more
+12 more
RestructuringVenture CapitalPrivate PlacementsDivestituresCapital MarketsStart-upsCorporate LawInvestor RelationsNegotiationStrategic PlanningStrategy DevelopmentStrategyLanguages Italian
- CPA, JD
From Jeff's professional profile.
Frequently asked questions
- Who is Jeff Parker?
- Jeff Parker is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company, having served as Managing Partner and Director since February 2018 prior to its IPO. He previously was President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) until its $69 million merger with PLx Pharma Inc., served as a board member of Abeona Therapeutics and as President and board member of MacroChem, and held executive roles at Bioenvision, Inc. Parker began his career as a certified public accountant at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.
- Where does Jeff Parker work?
- Jeff Parker is Founder of Parkervision.
- What companies did Jeff Parker found?
- Jeff Parker founded Parkervision.
- Where did Jeff Parker go to school?
- Jeff Parker studied at Albany Law School (JD, Law); Bucknell University (BSBA, Accounting and Business).
Same school
Also attended Albany Law School2
Also attended Bucknell University49
+ 43 more
Shared employers
Also worked at Digital Prime Technologies1
Also worked at Paul, Hastings, Janofsky & Walker LLP4
Also worked at Ernst & Young LLP1,162
+ 1,156 more





















%20(1).png)